Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
- PMID: 27423262
- PMCID: PMC4995441
- DOI: 10.1016/S0140-6736(16)30175-1
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
Abstract
Background: Overweight and obesity are increasing worldwide. To help assess their relevance to mortality in different populations we conducted individual-participant data meta-analyses of prospective studies of body-mass index (BMI), limiting confounding and reverse causality by restricting analyses to never-smokers and excluding pre-existing disease and the first 5 years of follow-up.
Methods: Of 10 625 411 participants in Asia, Australia and New Zealand, Europe, and North America from 239 prospective studies (median follow-up 13·7 years, IQR 11·4-14·7), 3 951 455 people in 189 studies were never-smokers without chronic diseases at recruitment who survived 5 years, of whom 385 879 died. The primary analyses are of these deaths, and study, age, and sex adjusted hazard ratios (HRs), relative to BMI 22·5-<25·0 kg/m(2).
Findings: All-cause mortality was minimal at 20·0-25·0 kg/m(2) (HR 1·00, 95% CI 0·98-1·02 for BMI 20·0-<22·5 kg/m(2); 1·00, 0·99-1·01 for BMI 22·5-<25·0 kg/m(2)), and increased significantly both just below this range (1·13, 1·09-1·17 for BMI 18·5-<20·0 kg/m(2); 1·51, 1·43-1·59 for BMI 15·0-<18·5) and throughout the overweight range (1·07, 1·07-1·08 for BMI 25·0-<27·5 kg/m(2); 1·20, 1·18-1·22 for BMI 27·5-<30·0 kg/m(2)). The HR for obesity grade 1 (BMI 30·0-<35·0 kg/m(2)) was 1·45, 95% CI 1·41-1·48; the HR for obesity grade 2 (35·0-<40·0 kg/m(2)) was 1·94, 1·87-2·01; and the HR for obesity grade 3 (40·0-<60·0 kg/m(2)) was 2·76, 2·60-2·92. For BMI over 25·0 kg/m(2), mortality increased approximately log-linearly with BMI; the HR per 5 kg/m(2) units higher BMI was 1·39 (1·34-1·43) in Europe, 1·29 (1·26-1·32) in North America, 1·39 (1·34-1·44) in east Asia, and 1·31 (1·27-1·35) in Australia and New Zealand. This HR per 5 kg/m(2) units higher BMI (for BMI over 25 kg/m(2)) was greater in younger than older people (1·52, 95% CI 1·47-1·56, for BMI measured at 35-49 years vs 1·21, 1·17-1·25, for BMI measured at 70-89 years; pheterogeneity<0·0001), greater in men than women (1·51, 1·46-1·56, vs 1·30, 1·26-1·33; pheterogeneity<0·0001), but similar in studies with self-reported and measured BMI.
Interpretation: The associations of both overweight and obesity with higher all-cause mortality were broadly consistent in four continents. This finding supports strategies to combat the entire spectrum of excess adiposity in many populations.
Funding: UK Medical Research Council, British Heart Foundation, National Institute for Health Research, US National Institutes of Health.
Copyright © 2016 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC-BY license. Published by Elsevier Ltd.. All rights reserved.
Figures




Comment in
-
BMI and mortality: the limits of epidemiological evidence.Lancet. 2016 Aug 20;388(10046):734-6. doi: 10.1016/S0140-6736(16)30949-7. Epub 2016 Jul 13. Lancet. 2016. PMID: 27423263 Free PMC article. No abstract available.
-
Comparative effects of the restriction method in two large observational studies of body mass index and mortality among adults.Eur J Clin Invest. 2017 Jun;47(6):415-421. doi: 10.1111/eci.12756. Epub 2017 May 8. Eur J Clin Invest. 2017. PMID: 28380255 Free PMC article.
-
Commentary on "A meta-analysis but not a systematic review: an evaluation of the Global BMI Mortality Collaboration".J Clin Epidemiol. 2017 Aug;88:30-32. doi: 10.1016/j.jclinepi.2017.04.006. Epub 2017 Apr 12. J Clin Epidemiol. 2017. PMID: 28411079 No abstract available.
-
A meta-analysis of individual participant data constructed to align with prior expert views: comments on Bhupathiraju et al.J Clin Epidemiol. 2017 Aug;88:33-36. doi: 10.1016/j.jclinepi.2017.04.005. Epub 2017 Apr 12. J Clin Epidemiol. 2017. PMID: 28411080 No abstract available.
-
A meta-analysis but not a systematic review: an evaluation of the Global BMI Mortality Collaboration.J Clin Epidemiol. 2017 Aug;88:21-29. doi: 10.1016/j.jclinepi.2017.04.007. Epub 2017 Apr 21. J Clin Epidemiol. 2017. PMID: 28435099
-
Body-mass index and all-cause mortality.Lancet. 2017 Jun 10;389(10086):2284. doi: 10.1016/S0140-6736(17)31436-8. Lancet. 2017. PMID: 28612743 No abstract available.
-
Body-mass index and all-cause mortality.Lancet. 2017 Jun 10;389(10086):2284-2285. doi: 10.1016/S0140-6736(17)31437-X. Lancet. 2017. PMID: 28612744 No abstract available.
-
Body-mass index and all-cause mortality - Authors' reply.Lancet. 2017 Jun 10;389(10086):2285-2286. doi: 10.1016/S0140-6736(17)31369-7. Lancet. 2017. PMID: 28612745 No abstract available.
-
Body-mass index and all-cause mortality.Lancet. 2017 Jun 10;389(10086):2285. doi: 10.1016/S0140-6736(17)31438-1. Lancet. 2017. PMID: 28612746 No abstract available.
-
Flawed methods and inappropriate conclusions for health policy on overweight and obesity: the Global BMI Mortality Collaboration meta-analysis.J Cachexia Sarcopenia Muscle. 2019 Feb;10(1):9-13. doi: 10.1002/jcsm.12378. Epub 2019 Jan 17. J Cachexia Sarcopenia Muscle. 2019. PMID: 30656860 Free PMC article.
References
-
- WHO . Obesity and overweight. Fact sheet N°311. World Health Organization; Geneva: 2015.
-
- WHO expert consultation Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157–163. - PubMed
-
- Asia Pacific Cohort Studies Collaboration Body mass index and cardiovascular disease in the Asia-Pacific region: an overview of 33 cohorts involving 310 000 participants. Int J Epidemiol. 2004;33:751–758. - PubMed
Publication types
MeSH terms
Grants and funding
- R01 DK058845/DK/NIDDK NIH HHS/United States
- RG/13/13/30194/BHF_/British Heart Foundation/United Kingdom
- P01 CA087969/CA/NCI NIH HHS/United States
- RG/08/014/24067/BHF_/British Heart Foundation/United Kingdom
- DK58845/DK/NIDDK NIH HHS/United States
- MR/L003120/1/MRC_/Medical Research Council/United Kingdom
- P30 DK046200/DK/NIDDK NIH HHS/United States
- U54 CA155626/CA/NCI NIH HHS/United States
- G9900923/MRC_/Medical Research Council/United Kingdom
- UM1 CA167552/CA/NCI NIH HHS/United States
- G0700474/MRC_/Medical Research Council/United Kingdom
- UM1 CA182910/CA/NCI NIH HHS/United States
- G0800270/MRC_/Medical Research Council/United Kingdom
- MR/K02700X/1/MRC_/Medical Research Council/United Kingdom
- 16491/CRUK_/Cancer Research UK/United Kingdom
- MC_QA137853/MRC_/Medical Research Council/United Kingdom
- UM1 CA176726/CA/NCI NIH HHS/United States
- P01 CA87969/CA/NCI NIH HHS/United States
- MC_UU_12013/1/MRC_/Medical Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical